biote Corp. (BTMD) Tops Q4 EPS by 11c, Revenue In Line; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
biote Corp. (BTMD) PT Raised to $9 at Roth/MKM
March 13, 2024 6:48 AM EDTRoth/MKM analyst George Kelly raised the price target on biote Corp. (NASDAQ: BTMD) to $9.00 (from $8.00) while maintaining a Buy rating.
The analyst comments "BTMD's 4Q report was largely as expected following its January pre-release. We remain positive given BTMD's compelling valuation and still... More
biote Corp. (BTMD) PT Raised to $8.24 at Jefferies
March 13, 2024 5:46 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on biote Corp. (NASDAQ: BTMD) to $8.24 (from $7.72) while maintaining a Buy rating.
The analyst comments "Q4 results largely in-line and 2024 guidance reaffirmed. New wellness offerings, the launch of the Men's health initiative, and... More
